1.07 USD
↘ 0.01 (0.93%)AT CLOSE (AS OF 07:31 PM EDT)
Fractyl Health, Inc. Common Stock
GUTSNASDAQ • USD
Market: CLOSED
Shares of Fractyl Health, Inc. Common Stock (GUTS) are trading at $1.07. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (6345.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest GUTS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.08
High?$1.12
Low?$1.02
Prev. Close?$1.08
Volume?363.0K
Avg. Volume?1.8M
VWAP?$1.07
Rel. Volume?0.21x
Bid / Ask
Bid?$0.90 × 100
Ask?$1.28 × 100
Spread?$0.38
Midpoint?$1.09
Valuation & Ratios
Market Cap?14.3M
Shares Out?N/A
Float?10.0M
Float %?75.3%
P/E Ratio?N/A
P/B Ratio?-8.60
EPS?-$7.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Themes
Employees
73
Market Cap
14.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2024-02-02
Address
3 VAN DE GRAAFF DRIVE
BURLINGTON, MA 01803
Phone: 781-902-8800
BURLINGTON, MA 01803
Phone: 781-902-8800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.64Distress
Confidence?43%Low
Short InterestLow
Short % of Float?2.66%Low
Short Interest?265.3K
Days to Cover?1.2
Free Float10.0M
Avg Daily Volume218.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.15Strong
Quick Ratio?3.15Strong
Cash Ratio?3.00Strong
Debt/Equity?-18.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-8.60CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?6,345.3%STRONG▾
Peers50
S&P97
ROA?-128.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-82439000
Enterprise Value?$-2367814
Fundamentals ratios updated end of day